These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11348531)

  • 21. Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review).
    Gehrig S; Efferth T
    Int J Mol Med; 2008 Oct; 22(4):411-9. PubMed ID: 18813846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cynaropicrin: the first plant natural product with in vivo activity against Trypanosoma brucei.
    Zimmermann S; Kaiser M; Brun R; Hamburger M; Adams M
    Planta Med; 2012 Apr; 78(6):553-6. PubMed ID: 22331812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new nonpolar N-hydroxy imidazoline lead compound with improved activity in a murine model of late-stage Trypanosoma brucei brucei infection is not cross-resistant with diamidines.
    Ríos Martínez CH; Miller F; Ganeshamoorthy K; Glacial F; Kaiser M; de Koning HP; Eze AA; Lagartera L; Herraiz T; Dardonville C
    Antimicrob Agents Chemother; 2015 Feb; 59(2):890-904. PubMed ID: 25421467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and in vivo evaluation of 28DAP010, a novel diamidine for treatment of second-stage African sleeping sickness.
    Wenzler T; Yang S; Patrick DA; Braissant O; Ismail MA; Tidwell RR; Boykin DW; Wang MZ; Brun R
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4452-63. PubMed ID: 24867978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eflornithine for the treatment of human African trypanosomiasis.
    Burri C; Brun R
    Parasitol Res; 2003 Jun; 90 Supp 1():S49-52. PubMed ID: 12811548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New treatment option for second-stage African sleeping sickness: in vitro and in vivo efficacy of aza analogs of DB289.
    Wenzler T; Boykin DW; Ismail MA; Hall JE; Tidwell RR; Brun R
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4185-92. PubMed ID: 19620327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and Characterization of FTY720 for the Treatment of Human African Trypanosomiasis.
    Jones AJ; Kaiser M; Avery VM
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1859-61. PubMed ID: 26666915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diamidines for human African trypanosomiasis.
    Paine MF; Wang MZ; Generaux CN; Boykin DW; Wilson WD; De Koning HP; Olson CA; Pohlig G; Burri C; Brun R; Murilla GA; Thuita JK; Barrett MP; Tidwell RR
    Curr Opin Investig Drugs; 2010 Aug; 11(8):876-83. PubMed ID: 20721830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-vitro Anti-trypanosomal and Cytotoxicity Evaluation of 3-methyl-3,4-dihydroquinazolin-2(1H)-one Derivatives.
    Jesumoroti OJ; Beteck RM; Legoabe LJ
    Drug Res (Stuttg); 2021 Jul; 71(6):335-340. PubMed ID: 33535253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro anti-trypanosomal activity of synthetic nitrofurantoin-triazole hybrids against Trypanosoma species causing human African trypanosomosis.
    Seetsi A; N'da DD; Molefe-Nyembe N; Suganuma K; Ramatla T; Thekisoe O
    Fundam Clin Pharmacol; 2024 Feb; 38(1):72-83. PubMed ID: 37479675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis.
    Nok AJ
    Parasitol Res; 2003 May; 90(1):71-9. PubMed ID: 12743807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delivery of antihuman African trypanosomiasis drugs across the blood-brain and blood-CSF barriers.
    Sekhar GN; Watson CP; Fidanboylu M; Sanderson L; Thomas SA
    Adv Pharmacol; 2014; 71():245-75. PubMed ID: 25307219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cattle movements and trypanosomes: restocking efforts and the spread of Trypanosoma brucei rhodesiense sleeping sickness in post-conflict Uganda.
    Selby R; Bardosh K; Picozzi K; Waiswa C; Welburn SC
    Parasit Vectors; 2013 Sep; 6(1):281. PubMed ID: 24289452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trypanosome alternative oxidase, a potential therapeutic target for sleeping sickness, is conserved among Trypanosoma brucei subspecies.
    Nakamura K; Fujioka S; Fukumoto S; Inoue N; Sakamoto K; Hirata H; Kido Y; Yabu Y; Suzuki T; Watanabe Y; Saimoto H; Akiyama H; Kita K
    Parasitol Int; 2010 Dec; 59(4):560-4. PubMed ID: 20688188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autophagic-related cell death of Trypanosoma brucei induced by bacteriocin AS-48.
    Martínez-García M; Bart JM; Campos-Salinas J; Valdivia E; Martínez-Bueno M; González-Rey E; Navarro M; Maqueda M; Cebrián R; Pérez-Victoria JM
    Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):203-212. PubMed ID: 29649664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of a melamino nitroheterocycle as a potential lead for the treatment of human african trypanosomiasis.
    Giordani F; Buschini A; Baliani A; Kaiser M; Brun R; Barrett MP; Pellacani C; Poli P; Gilbert IH
    Antimicrob Agents Chemother; 2014 Oct; 58(10):5747-57. PubMed ID: 25022590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 100 Years of Suramin.
    Wiedemar N; Hauser DA; Mäser P
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.
    Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB
    Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current chemotherapy of human African trypanosomiasis.
    Docampo R; Moreno SN
    Parasitol Res; 2003 Jun; 90 Supp 1():S10-3. PubMed ID: 12811544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The discovery of novel antitrypanosomal 4-phenyl-6-(pyridin-3-yl)pyrimidines.
    Robinson WJ; Taylor AE; Lauga-Cami S; Weaver GW; Arroo RRJ; Kaiser M; Gul S; Kuzikov M; Ellinger B; Singh K; Schirmeister T; Botana A; Eurtivong C; Bhambra AS
    Eur J Med Chem; 2021 Jan; 209():112871. PubMed ID: 33070078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.